Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has approved medicines that treat the underlying causes of multiple chronic, life-shortening genetic diseases — cystic fibrosis, sickle cell disease and transfusion-dependent beta thalassemia — and continues to advance clinical and research programs in these diseases. Vertex also has a robust clinical pipeline of investigational therapies across a range of modalities in other serious diseases where it has deep insight into causal human biology, including APOL1-mediated kidney disease, acute and neuropathic pain, type 1 diabetes, myotonic dystrophy type 1 and alpha-1 antitrypsin deficiency. Founded in 1989 in Cambridge, Mass., Vertex's global headquarters is now located in Boston's Innovation District and its international headquarters is in London. Additionally, the company has research and development sites and commercial offices in North America, Europe, Australia, Latin America and the Middle East. The successful candidate for the Process Development Engineering Senior Scientist (MSAT), Cell and Gene Therapy role will be responsible for Manufacturing Science and Technology (MSAT) activities for cell therapy products in the Type 1 Diabetes (T1D) program as well as the gene therapy (Casgevy) program. This role involves providing cross-functional leadership in technology development and transfer from Development to Clinical Manufacturing and Process Performance Qualification, including internal operations and potentially various CDMOs. The candidate will also plan and implement continuous improvement initiatives for life-cycle management within a cross-functional environment.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior
Education Level
Ph.D. or professional degree